ARTV Competitors & Alternatives
Compare Artiva Biotherapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
ARTV
Main Stock$6.15
Tradestie Score
51
Market Cap
$71.32M
Revenue Growth
-1.0%
Analyst Upside
+482.1%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANNX
Annexon, Inc. Common Stock
|
$3.75
|
$332.96M | - | 44 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.46
|
$328.62M | - | 49 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$6.87
|
$307.12M | - | 58 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.03
|
$304.12M | - | 56 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$14.59
|
$297.23M | - | 45 | Compare |
|
OMER
Omeros Corporation
|
$16.57
|
$281.75M | 13.3 | 66 | Compare |
|
DBVT
DBV Technologies S.A.
|
$9.75
|
$275.54M | - | 62 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$18.26
|
$269.08M | 0.1 | 50 | Compare |
|
PBYI
PUMA BIOTECHNOLOGY INC
|
$11.02
|
$265.45M | 21.2 | 34 | Compare |
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$5.39
|
$258.18M | - | 45 | Compare |
More ARTV Analysis
Data updated: Oct 24, 2026 | Industry: Biotechnology (SIC 2836)
220 stocks in this industry